Nanocellulose as a promising cell carrier for applications in regenerative medicine (8.4. 2021)
Cellulose in the form of a fabric has been used for thousands of years as a traditional wound dressing material. Nowadays, it can be used not only for passive wound covering, but also for active wound healing, e.g. with controlled delivery of various drugs or cells for regenerating the damaged tissue. A suitable form of cellulose for this purpose is nanocellulose, i.e. cellulose in the form of nanofibrils, simulating the architecture of the native extracellular matrix. This form of cellulose is produced by some species of bacteria, or can be isolated from higher plants, including wood. In our experiments, we have focused on the development of “intelligent” wound dressings, capable of delivering skin and stem cells into skin wounds. These dressings are based on electrically-charged cellulose nanofibrils, attached to a microfibrous cellulose fabric. Anionic nanocellulose provided a suitable substrate for the adhesion and growth of human dermal fibroblasts and human adipose tissue-derived stem cells, while cationic nanocellulose provided better support for cell-cell adhesion and for the formation of cell aggregates, which was apparent mainly in fibroblasts (Fig. 1). This difference was due to the preferential adsorption of albumin from the serum supplement of the culture medium, which is non-adhesive for cells, on cationic nanocellulose. However, both types of nanocellulose are useful in regenerative medicine. Anionic nanocellulose is suitable for creating continuous cell sheets, which can be delivered into the wound either spontaneously or after release from the substrate using cellulase enzymes, while cationic cellulose is suitable for creating cell spheroids, i.e. important structures for developing organoids and for tissue engineering.
Fig. 1 Morphology of normal human dermal fibroblasts (NHDFs; A) and human adipose tissue-derived stem cells (ADSCs; B), guided by the topography of cellulose meshes coated with anionic or cationic cellulose nanofibrils (a600, c600, respectively) after seven days of cultivation. 3D projection of microscopy images (front view and side view) of the cells on the material. F-actin of the cell cytoskeleton is stained in red, vinculin in the cells is stained in green. Confocal microscope with objective magnification 40x.
Pajorova J, Skogberg A, Hadraba D, Broz A, Travnickova M, Zikmundova M, Honkanen M, Hannula M, Lahtinen P, Tomkova M, Bacakova L, Kallio P. A cellulose mesh with charged nanocellulose coatings as a promising carrier of skin and stem cells for regenerative applications. Biomacromolecules, 2020, 21: 4857-4870, https://dx.doi.org/10.1021/acs.biomac.0c01097; IF = 6.092; DOI
Fat mass is controlled by the balance of triacylglycerol (TAG) degradation and synthesis. Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) are key players in TAG catabolism providing fatty acids (FAs) as energy substrates and metabolic intermediates. In collaboration with colleagues from University of Graz, Université de Montpellier and Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, we discovered that ATGL and HSL metabolize TAGs containing antidiabetic lipid mediators (FA esters of hydroxy FAs), distinctly controlling the release of bioactive lipids. Our paper connects lipolysis-mediated TAG metabolism with the regulation of antidiabetic signaling lipids.
Glycerol-bound FAHFAs in TAG, named TAG estolides, serve as metabolite reservoir of FAHFAs mobilized by lipases upon demand. We found that ATGL alone or co-activated by comparative gene identification-58 (CGI-58) efficiently liberated FAHFAs from TAG estolides with a preference for more compact substrates where the estolide branching point is located near the glycerol ester bond. ATGL was further involved in transesterification and remodeling reactions leading to the formation of TAG estolides with alternative acyl compositions. HSL represented a much more potent estolide bond hydrolase for both TAG estolides and free FAHFAs. FAHFA and TAG estolide accumulation in white adipose tissue of mice lacking HSL argued for a functional role of HSL in estolide catabolism in vivo.
K. Brejchova, F.P.W. Radner, L. Balas, V. Paluchova, T. Cajka, H. Chodounska, E. Kudova, M. Schratter, R. Schreiber, T. Durand, R. Zechner, O. Kuda. Distinct roles of adipose triglyceride lipase and hormone-sensitive lipase in the catabolism of triacylglycerol estolides. Proceedings of the National Academy of Sciences of the United States of America 118(2) (2021) e2020999118. IF = 9.412 DOI
Mitochondrial cardiolipin in adipose tissue as a novel target for treatment of cardiac cachexia (7.12. 2020)
More than a half of deaths in the Czech Republic is due to the cardiovascular disease, with most of the patients suffering from heart failure (HF). Long‐term prognosis of the HF-patients worsens by cachexia, which develops in a subgroup of the patients. Effective treatment of cachexia is missing. In collaboration of scientists at the Institute of Clinical and Experimental Medicine and the Institute of Physiology of the Czech Academy of Sciences in Prague, a study was conducted in advanced HF-patients (n = 52) undergoing heart transplantation. In adipose tissue from the vicinity of the diseased hearts of the cachectic patients, we have demonstrated (i) stronger neurohumoral stimulation of fatty acid (FA) release, and (ii) synthesis of unusual phospholipid cardiolipin (CL 70:6). This phospholipid may deteriorate mitochondrial functions in fat cells and accelerate wasting of the tissue. It could serve as a novel therapeutic target in cachexia.
In HF patients, lipolytic breakdown of triacylglycerols (TAG) in adipose tissue is activated in response to natriuretic peptides (NP), sympathetic nervous system (SNS) and renin-angiotensin-aldosteron system (RAAS). This results in increased release of FA and glycerol into circulation. In body weight-stable patients, the breakdown is balanced by TAG synthesis, which depends on glyceroneogenesis, de novo synthesis of FA (DNL), and FA re-esterification. These reactions require ATP, which is synthesized by oxidative phosphorylation (OXPHOS) linked to β-oxidation of FA in mitochondria. In the cachectic patients, lipolysis is overstimulated, in association with synthesis of CL 70:6 in adipose tissue. This lipid induces uncoupling of OXPHOS and thus inhibits synthesis of ATP, resulting in insufficient replenishment of the TAG pool in fat cells and wasting of adipose tissue.
Janovska P, Melenovsky V, Svobodova M, Havlenova T, Kratochvilova H, Haluzik M, Hoskova E, Pelikanova T, Kautzner J, Monzo L, Jurcova I, Adamcova K, Lenkova L, Buresova J, Rossmeisl M, Kuda O, Cajka T, Kopecky J. Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin. Journal of Cachexia, Sarcopenia and Muscle 2020; IF: 9.802 DOI
Neurosteroid pregnenolone sulfate - revealing of its site of action at the N-methyl-D-aspartate receptor (26.10. 2020)
NMDA receptors are ion channels involved in the transmission of electrical signals between nerve cells. Their insufficient function contributes to severe neuropsychiatric disorders such as schizophrenia or autism. NMDA receptor activity can be increased by a variety of compounds, including neurosteroids. In collaboration with the Institute of Organic Chemistry and Biochemistry CAS, we identified the binding site and elucidated the mechanism of action of the naturally occurring neurosteroid pregnenolone sulfate (PES). PES binds to the interface of membrane domains of the NMDA receptor in the closed state, and subsequent activation of the receptor by glutamate leads to a rearrangement of the membrane domains and stabilization of the open state of the NMDA receptor ion channel. These findings may contribute to the development of new drugs for the treatment of diseases associated with the dysfunction of the glutamatergic system.
The interaction of the PES molecule (green) with the membrane domains of the NMDA receptor in the open state was obtained by docking followed by molecular dynamics simulation. Amino acids involved in the interaction with the PES molecule are highlighted in red.
Hrčka Krausová B, Kysilov B, Černý J, Vyklický V, Smejkalová T, Ladislav M, Balík A, Kořínek M, Chodounská H, Kudová E, Vyklický ml. L. Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor. Journal of Neuroscience. 2020; 40 (31) 5922-5936. IF: 5.673 DOI
Dietary supplementation with Krill oil as a novel strategy to improve insulin sensitivity and reduce liver fat accumulation in obesity (20.10. 2020)
Lifestyle interventions including healthy nutrition represent an essential part of prevention and treatment strategies for metabolic sequelae of obesity. Krill oil as an extract from the Antarctic krill Euphausia superba (i.e. crustaceans found in Antarctic waters) is a relatively new source of omega-3 polyunsaturated fatty acids (Omega-3). It has been shown that dietary supplementation with Omega-3, usually as part of a triacylglycerol- or ethyl ester-based concentrate, may reduce inflammation and excessive amounts of fat in the liver (i.e. hepatic steatosis).
However, in obese type 2 diabetic patients, the use of Omega-3 may not necessarily improve insulin sensitivity and may impair long-term control of glucose metabolism. Therefore, we tested in obese mice whether supplementation with Omega-3 using an alternative lipid carrier, i.e. phospholipids from Kril oil, could have beneficial metabolic effects while also improving glucose metabolism and insulin sensitivity.
Our studies showed that Krill oil supplementation was able to reduce hepatic steatosis to a greater extent than Omega-3 given as triacylglycerols, and this effect of Krill oil was associated with improved insulin sensitivity in the liver and at the whole-body level. The beneficial effect of Krill oil on glucose homeostasis was associated not only with the improved bioavailability of Omega-3 (e.g. EPA, n-3 DPA) in tissues, but also with circulating levels of palmitoleic acid, a previously identified lipokine (i.e. hormone of a lipid nature) with insulin-sensitising effects whose content in Krill oil is incerased. In addition, Krill oil more effectively then Omega-3 triacylglycerols induced catabolism of fatty acids from the diet directly in the intestine, which could contribute to its strong antisteatotic effects in the liver. Our findings provide a general rationale for using Omega-3-containing phospholipids as nutritional supplements with potent insulin-sensitizing and antisteatotic effects.
Male C57BL/6N mice were fed for 8 weeks a corn oil-based high-fat diet (cHF) alone or supplemented with Omega-3 contained in triacylglycerols (cHF+ω3TG) or Krill oil phospholipids (cHF+ω3PL); lean controls were fed a low-fat standard chow (A). Administration of cHF worsened insulin sensitivity (determined by measuring the glucose infusion rate during the hyperinsulinemic-euglycemic clamp; B – upper part) and caused significant accumulation of lipids in the liver (i.e. hepatic steatosis; B – lower part). While insulin sensitivity was almost preserved and hepatic steatosis virtually eliminated in cHF+ω3PL mice, much less pronounced effects were observed in cHF+ω3TG mice. Favorable metabolic changes observed after Krill oil administration may be related to increased circulating levels of insulin-sensitizing lipokine palmitoleate (POA; C – upper part) and increased fatty acid catabolism directly in the intestinal tissue (POA; C – lower part).
Rossmeisl M, Pavlisova J, Bardova K, Kalendova V, Buresova J, Kuda O, Kroupova P, Stankova B, Tvrzicka E, Fiserova E, Horakova O, Kopecky J. Increased plasma levels of palmitoleic acid may contribute to beneficial effects of Krill oil on glucose homeostasis in dietary obese mice. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(8):158732. IF: 4.519 DOI
Kroupova P, van Schothorst EM, Keijer J, Bunschoten A, Vodicka M, Irodenko I, Oseeva M, Zacek P, Kopecky J, Rossmeisl M, Horakova O. Omega-3 Phospholipids from Krill Oil Enhance Intestinal Fatty Acid Oxidation More Effectively than Omega-3 Triacylglycerols in High-Fat Diet-Fed Obese Mice. Nutrients. 2020;12(7):2037. IF: 4.546 DOI